Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Mark Lappe > Profile

Mark Lappe

Affiliations

  • Chief Executive Officer at Inhibrx Biosciences Inc. (INBX), 2024-09-16
  • Chief Executive Officer at Inhibrx Inc. (INBX), 2024-05-30
  • Large Shareholder at Aeolus Pharmaceuticals Inc. (AOLS), 2011-03-17
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Inhibrx Biosciences Inc.
 INBX $17.13 13,037 Officer, Director 705,548 2024-09-16 Filing
Inhibrx Biosciences Inc.
 INBX $15.05 26,963 Officer, Director 692,511 2024-09-12 Filing
Inhibrx Biosciences Inc.
 INBX $15.19 8,500 Officer, Director 665,548 2024-09-10 Filing
Inhibrx Biosciences Inc.
 INBX $15.21 9,500 Officer, Director 657,048 2024-09-09 Filing
Inhibrx Biosciences Inc.
 INBX $15.29 26,000 Officer, Director 647,548 2024-09-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Inhibrx Inc.
 INBX $25.02 60 Officer, Director 2,486,192 2023-02-28 Filing
Inhibrx Inc.
 INBX $26.11 63 Officer, Director 2,486,252 2023-01-24 Filing
Inhibrx Inc.
 INBX $25.71 4,272 Officer, Director 2,486,315 2023-01-24 Filing
Inhibrx Inc.
 INBX $25.36 21,665 Officer, Director 2,490,587 2023-01-23 Filing
Inhibrx Inc.
 INBX $26.29 754 Officer, Director 2,512,252 2022-12-19 Filing